Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

Cell quality control mechanisms maintain stemness and differentiation potential of P19 embryonic carcinoma cells.

Magalhães-Novais S, Bermejo-Millo JC, Loureiro R, Mesquita KA, Domingues MR, Maciel E, Melo T, Baldeiras I, Erickson JR, Holy J, Potes Y, Coto-Montes A, Oliveira PJ, Vega-Naredo I.

Autophagy. 2019 Apr 16:1-21. doi: 10.1080/15548627.2019.1607694. [Epub ahead of print]

PMID:
30990357
2.

Lower sarcoplasmic reticulum Ca2+ threshold for triggering afterdepolarizations in diabetic rat hearts.

Popescu I, Yin G, Velmurugan S, Erickson JR, Despa F, Despa S.

Heart Rhythm. 2019 May;16(5):765-772. doi: 10.1016/j.hrthm.2018.11.001. Epub 2018 Nov 7.

PMID:
30414461
3.

Inhibition of calcium/calmodulin-dependent kinase II restores contraction and relaxation in isolated cardiac muscle from type 2 diabetic rats.

Daniels LJ, Wallace RS, Nicholson OM, Wilson GA, McDonald FJ, Jones PP, Baldi JC, Lamberts RR, Erickson JR.

Cardiovasc Diabetol. 2018 Jun 14;17(1):89. doi: 10.1186/s12933-018-0732-x.

4.

Cardiomyocyte Functional Etiology in Heart Failure With Preserved Ejection Fraction Is Distinctive-A New Preclinical Model.

Curl CL, Danes VR, Bell JR, Raaijmakers AJA, Ip WTK, Chandramouli C, Harding TW, Porrello ER, Erickson JR, Charchar FJ, Kompa AR, Edgley AJ, Crossman DJ, Soeller C, Mellor KM, Kalman JM, Harrap SB, Delbridge LMD.

J Am Heart Assoc. 2018 Jun 1;7(11). pii: e007451. doi: 10.1161/JAHA.117.007451.

5.

CaMKII in Vascular Signalling: "Friend or Foe"?

Ebenebe OV, Heather A, Erickson JR.

Heart Lung Circ. 2018 May;27(5):560-567. doi: 10.1016/j.hlc.2017.12.003. Epub 2017 Dec 19. Review.

PMID:
29409723
6.

Learning from regeneration research organisms: The circuitous road to scar free wound healing.

Erickson JR, Echeverri K.

Dev Biol. 2018 Jan 15;433(2):144-154. doi: 10.1016/j.ydbio.2017.09.025. Epub 2017 Nov 24. Review.

7.

A novel role for SALL4 during scar-free wound healing in axolotl.

Erickson JR, Gearhart MD, Honson DD, Reid TA, Gardner MK, Moriarity BS, Echeverri K.

NPJ Regen Med. 2016;1. pii: 16016. doi: 10.1038/npjregenmed.2016.16. Epub 2016 Dec 8.

8.

Identification of Conserved and Novel MicroRNAs during Tail Regeneration in the Mexican Axolotl.

Gearhart MD, Erickson JR, Walsh A, Echeverri K.

Int J Mol Sci. 2015 Sep 11;16(9):22046-61. doi: 10.3390/ijms160922046.

9.

S-Nitrosylation Induces Both Autonomous Activation and Inhibition of Calcium/Calmodulin-dependent Protein Kinase II δ.

Erickson JR, Nichols CB, Uchinoumi H, Stein ML, Bossuyt J, Bers DM.

J Biol Chem. 2015 Oct 16;290(42):25646-56. doi: 10.1074/jbc.M115.650234. Epub 2015 Aug 27.

10.

The role of CaMKII in diabetic heart dysfunction.

Daniels L, Bell JR, Delbridge LM, McDonald FJ, Lamberts RR, Erickson JR.

Heart Fail Rev. 2015 Sep;20(5):589-600. doi: 10.1007/s10741-015-9498-3. Review.

PMID:
26198034
11.

CaMKIIδ mediates β-adrenergic effects on RyR2 phosphorylation and SR Ca(2+) leak and the pathophysiological response to chronic β-adrenergic stimulation.

Grimm M, Ling H, Willeford A, Pereira L, Gray CB, Erickson JR, Sarma S, Respress JL, Wehrens XH, Bers DM, Brown JH.

J Mol Cell Cardiol. 2015 Aug;85:282-91. doi: 10.1016/j.yjmcc.2015.06.007. Epub 2015 Jun 14.

12.

Novel Epac fluorescent ligand reveals distinct Epac1 vs. Epac2 distribution and function in cardiomyocytes.

Pereira L, Rehmann H, Lao DH, Erickson JR, Bossuyt J, Chen J, Bers DM.

Proc Natl Acad Sci U S A. 2015 Mar 31;112(13):3991-6. doi: 10.1073/pnas.1416163112. Epub 2015 Mar 17.

13.

In vivo modulation and quantification of microRNAs during axolotl tail regeneration.

Erickson JR, Echeverri K.

Methods Mol Biol. 2015;1290:159-67. doi: 10.1007/978-1-4939-2495-0_13.

14.

Cardiac CaMKIIδ splice variants exhibit target signaling specificity and confer sex-selective arrhythmogenic actions in the ischemic-reperfused heart.

Bell JR, Raaijmakers AJ, Curl CL, Reichelt ME, Harding TW, Bei A, Ng DC, Erickson JR, Vila Petroff M, Harrap SB, Delbridge LM.

Int J Cardiol. 2015 Feb 15;181:288-96. doi: 10.1016/j.ijcard.2014.11.159. Epub 2014 Nov 26.

PMID:
25539453
15.

Ca(2+) /calmodulin dependent kinase II: a critical mediator in determining reperfusion outcomes in the heart?

Bell JR, Erickson JR, Delbridge LM.

Clin Exp Pharmacol Physiol. 2014 Nov;41(11):940-6. doi: 10.1111/1440-1681.12301. Review.

PMID:
25283076
16.

Mitochondrial metabolism directs stemness and differentiation in P19 embryonal carcinoma stem cells.

Vega-Naredo I, Loureiro R, Mesquita KA, Barbosa IA, Tavares LC, Branco AF, Erickson JR, Holy J, Perkins EL, Carvalho RA, Oliveira PJ.

Cell Death Differ. 2014 Oct;21(10):1560-74. doi: 10.1038/cdd.2014.66. Epub 2014 May 16.

17.

Mechanisms of CaMKII Activation in the Heart.

Erickson JR.

Front Pharmacol. 2014 Apr 2;5:59. doi: 10.3389/fphar.2014.00059. eCollection 2014. Review.

18.

Mechanochemotransduction during cardiomyocyte contraction is mediated by localized nitric oxide signaling.

Jian Z, Han H, Zhang T, Puglisi J, Izu LT, Shaw JA, Onofiok E, Erickson JR, Chen YJ, Horvath B, Shimkunas R, Xiao W, Li Y, Pan T, Chan J, Banyasz T, Tardiff JC, Chiamvimonvat N, Bers DM, Lam KS, Chen-Izu Y.

Sci Signal. 2014 Mar 18;7(317):ra27. doi: 10.1126/scisignal.2005046.

19.

CD8+ T cell-independent tumor regression induced by Fc-OX40L and therapeutic vaccination in a mouse model of glioma.

Murphy KA, Erickson JR, Johnson CS, Seiler CE, Bedi J, Hu P, Pluhar GE, Epstein AL, Ohlfest JR.

J Immunol. 2014 Jan 1;192(1):224-33. doi: 10.4049/jimmunol.1301633. Epub 2013 Nov 29.

20.

Intracellular signalling mechanism responsible for modulation of sarcolemmal ATP-sensitive potassium channels by nitric oxide in ventricular cardiomyocytes.

Zhang DM, Chai Y, Erickson JR, Brown JH, Bers DM, Lin YF.

J Physiol. 2014 Mar 1;592(5):971-90. doi: 10.1113/jphysiol.2013.264697. Epub 2013 Nov 25.

21.

Diabetic hyperglycaemia activates CaMKII and arrhythmias by O-linked glycosylation.

Erickson JR, Pereira L, Wang L, Han G, Ferguson A, Dao K, Copeland RJ, Despa F, Hart GW, Ripplinger CM, Bers DM.

Nature. 2013 Oct 17;502(7471):372-6. doi: 10.1038/nature12537. Epub 2013 Sep 29.

22.

Murine thymic selection quantified using a unique method to capture deleted T cells.

Stritesky GL, Xing Y, Erickson JR, Kalekar LA, Wang X, Mueller DL, Jameson SC, Hogquist KA.

Proc Natl Acad Sci U S A. 2013 Mar 19;110(12):4679-84. doi: 10.1073/pnas.1217532110. Epub 2013 Mar 4.

23.

Comprehensive immune monitoring reveals profound immunological changes in pancreas after kidney (PAK) transplant recipients.

Kudva YC, Erickson JR, Parsaik A, Rostambeigi N, Thapa P, Abraham RS.

Hum Immunol. 2013 Jun;74(6):738-45. doi: 10.1016/j.humimm.2013.02.004. Epub 2013 Mar 7.

PMID:
23474226
24.

An in vivo immunotherapy screen of costimulatory molecules identifies Fc-OX40L as a potent reagent for the treatment of established murine gliomas.

Murphy KA, Lechner MG, Popescu FE, Bedi J, Decker SA, Hu P, Erickson JR, O'Sullivan MG, Swier L, Salazar AM, Olin MR, Epstein AL, Ohlfest JR.

Clin Cancer Res. 2012 Sep 1;18(17):4657-68. doi: 10.1158/1078-0432.CCR-12-0990. Epub 2012 Jul 10.

25.

Fluorescence resonance energy transfer-based sensor Camui provides new insight into mechanisms of calcium/calmodulin-dependent protein kinase II activation in intact cardiomyocytes.

Erickson JR, Patel R, Ferguson A, Bossuyt J, Bers DM.

Circ Res. 2011 Sep 16;109(7):729-38. doi: 10.1161/CIRCRESAHA.111.247148. Epub 2011 Aug 11.

26.

CaMKII in the cardiovascular system: sensing redox states.

Erickson JR, He BJ, Grumbach IM, Anderson ME.

Physiol Rev. 2011 Jul;91(3):889-915. doi: 10.1152/physrev.00018.2010. Review.

27.

CaMKII and its role in cardiac arrhythmia.

Erickson JR, Anderson ME.

J Cardiovasc Electrophysiol. 2008 Dec;19(12):1332-6. doi: 10.1111/j.1540-8167.2008.01295.x. Epub 2008 Sep 17.

PMID:
18803570
28.

A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation.

Erickson JR, Joiner ML, Guan X, Kutschke W, Yang J, Oddis CV, Bartlett RK, Lowe JS, O'Donnell SE, Aykin-Burns N, Zimmerman MC, Zimmerman K, Ham AJ, Weiss RM, Spitz DR, Shea MA, Colbran RJ, Mohler PJ, Anderson ME.

Cell. 2008 May 2;133(3):462-74. doi: 10.1016/j.cell.2008.02.048.

29.

Functional characterization of parvalbumin from the Arctic cod (Boreogadus saida): similarity in calcium affinity among parvalbumins from polar teleosts.

Erickson JR, Moerland TS.

Comp Biochem Physiol A Mol Integr Physiol. 2006 Feb;143(2):228-33. Epub 2006 Jan 18.

PMID:
16412673
30.

A competition assay of magnesium affinity for EF-hand proteins based on the fluorescent indicator magnesium green.

Erickson JR, Moerland TS.

Anal Biochem. 2005 Oct 15;345(2):343-5. No abstract available.

PMID:
16083847
31.

Temperature sensitivity of calcium binding for parvalbumins from Antarctic and temperate zone teleost fishes.

Erickson JR, Sidell BD, Moerland TS.

Comp Biochem Physiol A Mol Integr Physiol. 2005 Feb;140(2):179-85. Epub 2005 Jan 11.

PMID:
15748857
32.

Intravesical resiniferatoxin for refractory detrusor hyperreflexia: a multicenter, blinded, randomized, placebo-controlled trial.

Kim JH, Rivas DA, Shenot PJ, Green B, Kennelly M, Erickson JR, O'Leary M, Yoshimura N, Chancellor MB.

J Spinal Cord Med. 2003 Winter;26(4):358-63.

PMID:
14992337
33.

Can higher doses of oxybutynin improve efficacy in neurogenic bladder?

Bennett N, O'Leary M, Patel AS, Xavier M, Erickson JR, Chancellor MB.

J Urol. 2004 Feb;171(2 Pt 1):749-51.

PMID:
14713802
34.

Effect of controlled-release oxybutynin on neurogenic bladder function in spinal cord injury.

O'Leary M, Erickson JR, Smith CP, McDermott C, Horton J, Chancellor MB.

J Spinal Cord Med. 2003 Summer;26(2):159-62.

PMID:
12828295
35.

Identification of a phosphothionate analogue of lysophosphatidic acid (LPA) as a selective agonist of the LPA3 receptor.

Hasegawa Y, Erickson JR, Goddard GJ, Yu S, Liu S, Cheng KW, Eder A, Bandoh K, Aoki J, Jarosz R, Schrier AD, Lynch KR, Mills GB, Fang X.

J Biol Chem. 2003 Apr 4;278(14):11962-9. Epub 2003 Jan 27.

36.

Well-being in Hispanic and non-Hispanic white survivors of breast cancer.

Dirksen SR, Erickson JR.

Oncol Nurs Forum. 2002 Jun;29(5):820-6.

PMID:
12058156
37.

Neurovesical dysfunction in postural tachycardia syndrome (POTS).

O'Leary ML, Smith CP, Erickson JR, Eidelman BH, Chancellor MB.

Int Urogynecol J Pelvic Floor Dysfunct. 2002;13(2):139-40.

PMID:
12054183
38.

Critical role of lysophospholipids in the pathophysiology, diagnosis, and management of ovarian cancer.

Mills GB, Eder A, Fang X, Hasegawa Y, Mao M, Lu Y, Tanyi J, Tabassam FH, Wiener J, Lapushin R, Yu S, Parrott JA, Compton T, Tribley W, Fishman D, Stack MS, Gaudette D, Jaffe R, Furui T, Aoki J, Erickson JR.

Cancer Treat Res. 2002;107:259-83. Review.

PMID:
11775454
39.

Growth and development in term infants fed long-chain polyunsaturated fatty acids: a double-masked, randomized, parallel, prospective, multivariate study.

Auestad N, Halter R, Hall RT, Blatter M, Bogle ML, Burks W, Erickson JR, Fitzgerald KM, Dobson V, Innis SM, Singer LT, Montalto MB, Jacobs JR, Qiu W, Bornstein MH.

Pediatrics. 2001 Aug;108(2):372-81.

PMID:
11483802
40.

Lysophosphatidic acid and ovarian cancer: a paradigm for tumorogenesis and patient management.

Erickson JR, Hasegawa Y, Fang X, Eder A, Mao M, Furui T, Aoki J, Morris A, Mills GB.

Prostaglandins Other Lipid Mediat. 2001 Apr;64(1-4):63-81. Review. No abstract available.

PMID:
11324708
41.

Lysophosphatidic acid prevents apoptosis in fibroblasts via G(i)-protein-mediated activation of mitogen-activated protein kinase.

Fang X, Yu S, LaPushin R, Lu Y, Furui T, Penn LZ, Stokoe D, Erickson JR, Bast RC Jr, Mills GB.

Biochem J. 2000 Nov 15;352 Pt 1:135-43.

42.

Analysis of the EDG2 receptor based on the structure/activity relationship of LPA.

Erickson JR, Espinal G, Mills GB.

Ann N Y Acad Sci. 2000 Apr;905:279-81. No abstract available.

PMID:
10818464
43.

Lysophospholipid growth factors in the initiation, progression, metastases, and management of ovarian cancer.

Fang X, Gaudette D, Furui T, Mao M, Estrella V, Eder A, Pustilnik T, Sasagawa T, Lapushin R, Yu S, Jaffe RB, Wiener JR, Erickson JR, Mills GB.

Ann N Y Acad Sci. 2000 Apr;905:188-208. Review.

PMID:
10818454
44.

Determinants of receptor subtype specificity in the LPA-like lipid mediator family.

Tigyi G, Fisher DJ, Lilion K, Guo Z, Virag T, Sun G, Miller DD, Murakami-Murofushi K, Kobayashi S, Erickson JR.

Adv Exp Med Biol. 1999;469:245-51. No abstract available.

PMID:
10667337
45.

Tolterodine for overactive bladder: time to onset of action, preferred dosage, and 9-month follow-up.

Atan A, Konety BR, Erickson JR, Yokoyama T, Kim DY, Chancellor MB.

Tech Urol. 1999 Jun;5(2):67-70.

PMID:
10458657
46.

C3 toxin activates the stress signaling pathways, JNK and p38, but antagonizes the activation of AP-1 in rat-1 cells.

Beltman J, Erickson JR, Martin GA, Lyons JF, Cook SJ.

J Biol Chem. 1999 Feb 5;274(6):3772-80.

47.

Naturally occurring analogs of lysophosphatidic acid elicit different cellular responses through selective activation of multiple receptor subtypes.

Fischer DJ, Liliom K, Guo Z, Nusser N, Virág T, Murakami-Murofushi K, Kobayashi S, Erickson JR, Sun G, Miller DD, Tigyi G.

Mol Pharmacol. 1998 Dec;54(6):979-88.

PMID:
9855625
48.

Identification of a novel growth factor-like lipid, 1-O-cis-alk-1'-enyl-2-lyso-sn-glycero-3-phosphate (alkenyl-GP) that is present in commercial sphingolipid preparations.

Liliom K, Fischer DJ, Virág T, Sun G, Miller DD, Tseng JL, Desiderio DM, Seidel MC, Erickson JR, Tigyi G.

J Biol Chem. 1998 May 29;273(22):13461-8.

49.

Maspin is an intracellular serpin that partitions into secretory vesicles and is present at the cell surface.

Pemberton PA, Tipton AR, Pavloff N, Smith J, Erickson JR, Mouchabeck ZM, Kiefer MC.

J Histochem Cytochem. 1997 Dec;45(12):1697-706.

PMID:
9389773
50.

Modulation of the immune system by human milk and infant formula containing nucleotides.

Pickering LK, Granoff DM, Erickson JR, Masor ML, Cordle CT, Schaller JP, Winship TR, Paule CL, Hilty MD.

Pediatrics. 1998 Feb;101(2):242-9.

PMID:
9445498

Supplemental Content

Loading ...
Support Center